Correlation Between Roivant Sciences and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Roivant Sciences and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Maravai Lifesciences.
Diversification Opportunities for Roivant Sciences and Maravai Lifesciences
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Roivant and Maravai is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between Roivant Sciences and Maravai Lifesciences
Given the investment horizon of 90 days Roivant Sciences is expected to generate 0.26 times more return on investment than Maravai Lifesciences. However, Roivant Sciences is 3.88 times less risky than Maravai Lifesciences. It trades about 0.02 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.06 per unit of risk. If you would invest 1,212 in Roivant Sciences on September 12, 2024 and sell it today you would earn a total of 12.00 from holding Roivant Sciences or generate 0.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Roivant Sciences vs. Maravai Lifesciences Holdings
Performance |
Timeline |
Roivant Sciences |
Maravai Lifesciences |
Roivant Sciences and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Roivant Sciences and Maravai Lifesciences
The main advantage of trading using opposite Roivant Sciences and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |